71 results on '"Sankaranarayanan, Rengaswamy"'
Search Results
2. Perspective on oral cancer screening: Time for implementation research and beyond
3. Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination
4. Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries
5. Impact of HPV vaccination on HPV-related oral infections
6. Awareness, perceptions, and choices of physicians pertaining to human papillomavirus (HPV) vaccination in India: A formative research study
7. Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling study
8. Awareness, Perceptions, and Choices of Physicians Pertaining to Human Papillomavirus (Hpv) Vaccination in India: A Formative Research Study
9. Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study
10. Patterns of care of breast cancer patients in Morocco – A study of variations in patient profile, tumour characteristics and standard of care over a decade
11. Reply to: Chronic Pain assessment and management during post-treatment follow up should be considered as a high value quality indicator for specialist breast cancer center
12. HPV DNA genotyping, HPV E6*I mRNA detection, and p16INK4a/Ki-67 staining in Belgian head and neck cancer patient specimens, collected within the HPV-AHEAD study
13. Prevention is life- and cost-saving
14. Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccines
15. Thermal ablation versus cryotherapy or loop excision to treat women positive for cervical precancer on visual inspection with acetic acid test: pilot phase of a randomised controlled trial
16. Current status of human papillomavirus vaccination in India's cervical cancer prevention efforts
17. Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years – updated evidence from Indian follow-up cohort study
18. Feasibility and Safety of an HPV-Based 'See-and-Treat' Approach with Thermal Ablation for Cervical Cancer Prevention in Rural China: Baseline Evaluation from a Prospective Study
19. Durability of clinical performance afforded by self-collected HPV testing: A 15-year cohort study in China
20. Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study
21. Are two doses of human papillomavirus vaccine sufficient for girls aged 15–18 years? Results from a cohort study in India
22. Integrated prevention for global cancer control
23. Universal health coverage and intersectoral action for health: key messages from Disease Control Priorities, 3rd edition
24. Population-based cancer screening programmes in low-income and middle-income countries: regional consultation of the International Cancer Screening Network in India
25. Tackling cancer burden in low-income and middle-income countries: Morocco as an exemplar
26. Longitudinal performance of self-collected human papilloma virus testing and other mainstream strategies in detecting prevalent and incident cervical precancer: a 15-year cohort study in china
27. Comparative accuracy of Pap smear and HPV screening in Ubon Ratchathani in Thailand
28. Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries
29. Cancer early detection program based on awareness and clinical breast examination: Interim results from an urban community in Mumbai, India
30. Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd edition
31. Clinical trial to implementation: Cost and effectiveness considerations for scaling up cervical cancer screening in low- and middle-income countries
32. Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study
33. Cancer in the 25×25 non-communicable disease targets
34. OI335 Importance of long-term visual screening on tongue cancer incidence
35. Cervical cancer mortality in India – Authors' reply
36. Cancer prevention and care in India: an unfinished agenda
37. Erratum to: “Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer” [Vaccine 30S5 (2012) F88–F99]
38. Infrastructure Requirements for Human Papillomavirus Vaccination and Cervical Cancer Screening in Sub-Saharan Africa
39. Recommendations for Cervical Cancer Prevention in Sub-Saharan Africa
40. Comprehensive Control of Human Papillomavirus Infections and Related Diseases
41. Comprehensive Control of Human Papillomavirus Infections and Related Diseases
42. Comprehensive Control of Human Papillomavirus Infections and Related Diseases
43. Comprehensive Control of Human Papillomavirus Infections and Related Diseases
44. Long term effect of visual screening on oral cancer incidence and mortality in a randomized trial in Kerala, India
45. Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
46. New Technologies and Procedures for Cervical Cancer Screening
47. Verbal-autopsy-based projection of cancer deaths in India
48. Visual inspection methods for cervical cancer prevention
49. Estimation of disease prevalence, true positive rate, and false positive rate of two screening tests when disease verification is applied on only screen-positives: A hierarchical model using multi-center data
50. Acceptability and uptake of HPV vaccine in Argentina before its inclusion in the immunization program: A population-based survey
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.